NICE bends to pressure over Lucentis
December 14, 2007Sales and Marketing AMD, Lucentis, NICE
NICE is set to change its guidance for blindness treatment Lucentis following a barrage of complaints over its failure to …
Get ready for inspection
December 13, 2007Research and Development MHRA, inspection, reg affairs
No one looks forward to receiving a letter from the MHRA (Medicines and Healthcare products Regulatory Agency) inspectorate announcing their …
Herefordshire pioneers PCT and council merger
December 12, 2007Sales and Marketing
A revolutionary new 'public service trust' has been created in Herefordshire, and will be the first to integrate a PCT …
Supply chain could inflate prices, says watchdog
December 12, 2007Sales and Marketing
The NHS could face steeper prices on drugs due to manufacturers adopting a new restrictive distribution model, according to a …
Stout to quit as GSK restructures
December 10, 2007Sales and Marketing GSK, restructure
GlaxoSmithKline has unveiled new appointments to its board of directors and the departure of its current president of Pharmaceuticals David …
Pharma calls for European ‘patient information partnerships’
December 10, 2007Medical Communications
Pharmaceutical industry leaders are hoping that 2008 will see a breakthrough on one of the most contentious issues in European …
Avandia suffering less in Europe
December 10, 2007Sales and Marketing Avandia, diabetes
New research by market data company TNS Healthcare suggests that fewer patients are being taken off Avandia in Europe than …
GP leader hits out at regulator’s demands
December 10, 2007Sales and Marketing
The chairman of the NHS Alliance has criticised a new report which says GPs are not carrying out 'basic work' …
Eisai gets go ahead for Alzheimer’s appeal
December 10, 2007Alzheimer's, Eisai, NICE
Eisai is to make one more legal challenge to NICE by taking its case on Alzheimer’s drugs to the Court …
ABPI names new president
December 10, 2007ABPI
AstraZeneca's Chris Brinsmead has been named as the next president of the ABPI.He will take over from the current ABPI …
Latest news from Datamonitor
December 10, 2007Research and Development
Adventrx completes enrolment for breast cancer trialAdventrx Pharmaceuticals has completed patient enrolment in its Phase II clinical trial of CoFactor …
Safety first
December 10, 2007Research and Development, Sales and Marketing clinical trials, drug development, drug safety
There is a tide of change in drug safety within the pharmaceutical industry. Internal and external forces are pushing drug …
NICE approves Novartis asthma jab
November 30, 2007Sales and Marketing
NICE has recommended Novartis' injection Xolair for asthma patients whose condition cannot be controlled by conventional first-line treatments. Patients with …
New GP practices for deprived areas
November 30, 2007Health secretary Alan Johnson has unveiled plans to open 100 new practices in under-doctored areas within the next three years. …
Ezetrol receives NICE approval
November 30, 2007Sales and Marketing
NICE has approved Ezetrol, the cholesterol-lowering drug marketed by MSD and Schering-Plough. Data shows the drug significantly reduces bad cholesterol …
Divert money from Herceptin, says radiotherapy leader
November 30, 2007Sales and Marketing
Money currently being spent on Herceptin for breast cancer patients could be better spent on providing radiotherapy, a leader in …
Sanofi and Regeneron sign antibody deal
November 30, 2007Research and Development
Sanofi-Aventis has increased its stake in Regeneron and will collaborate with the US biotech company on new antibody research.The companies …
Short sighted pharma undermining its own future, says Oxfam
November 30, 2007Sales and Marketing
Pharmaceutical companies are damaging their businesses by blocking access to drugs for millions of people in the developing world, according …
Wyeth kidney cancer drug approved in Europe
November 29, 2007Sales and Marketing
Wyeth's orphan cancer drug Torisel has been approved in Europe for difficult to treat cases of advanced renal cell carcinoma.It …
European approval for Merck’s cyanide antidote
November 29, 2007Sales and Marketing
European regulators have approved Merck Serono's cyanide poisoning cure Cyanokit for use in adults and children. Cyanide poisoning is primarily …
